Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?

To: StockDoc who wrote (793)	4/1/1998 3:19:00 PM
From: techbull	Respond to of 887

Sinil Kim is the inventor of Depo foam and I thought that that was who my response was targeted for. Thanks for the clarification. I think now that I am just going to focus on the delivery technology and not get caught up with everyone else's far more superior understanding of medical trials and the statistics behind them. I want to be positive and I'm not sure if it was you or someone else you posted that it is much better to focus on the future and not belabor the past.

To: StockDoc who wrote (793)	4/1/1998 4:06:00 PM
From: BD	Read Replies (1) \| Respond to of 887

If they didn't sway any of their oncologist colleagues into using it then I draw the conclusion there was no phase III or IV enrollment. What am I missing here?

To: StockDoc who wrote (793)	4/8/1998 7:41:00 AM
From: Bob Barels	Read Replies (2) \| Respond to of 887

DEPO is dead. Nothing new from the conference. N.V. Katre, Ph.D from DEPO spoke and said nothing. Words like "uniquely different" "preclinical", "potential" "future" " the rate of release may be controlled" were all over the presentation. Bottom line is : we need funding. Any suckers out there? The only sentence with some meaning was "... The DEPOFOAM formulation of an anti-cancer drug, cytarabine, has undergone clinical trials and is in the final stage of review by the U.S. FDA." On questions about timing, previous failure, Dr. Katre had no comments. My suggestion is get out as soon as you can. This company is a failure. Key people have left the company with huge profits and some others are left to collect the remains. IMO that it will be $1 stock by the end of the year.